Search Results - Xiaojing Shi
- Showing 1 - 4 results of 4
-
1
Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors by Zhenzhen Liu, Taoqian Zhao, Zhonghua Li, Kai Sun, Yundong Fu, Ting Cheng, Jimin Guo, Bin Yu, Xiaojing Shi, Hongmin Liu
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor by Pengxing He, Shenghui Niu, Shuai Wang, Xiaojing Shi, Siqi Feng, Linna Du, Xuyang Zhang, Zhilu Ma, Bin Yu, Hongmin Liu
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma by Zhaoming Lu, Xiaojing Shi, Fanghua Gong, Shenglei Li, Yang Wang, Yandan Ren, Mengyin Zhang, Bin Yu, Yan Li, Wen Zhao, Jianying Zhang, Guiqin Hou
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro by Lulu Si, Lulu Si, Tianjiao Lai, Tianjiao Lai, Junru Zhao, Yuxi Jin, Yuxi Jin, Meng Qi, Meng Qi, Mingyue Li, Mingyue Li, Hanlin Fu, Hanlin Fu, Xiaojing Shi, Liying Ma, Liying Ma, Liying Ma, Ruixia Guo, Ruixia Guo
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book